Velsera

Velsera is a precision medicine technology company founded in 2023. It operates across the United States, Europe, and Asia, serving clients in life sciences, clinical diagnostics, pharmaceuticals, NGS assay manufacturing, and non-profit sectors.

The company's platform integrates AI-enhanced software with expert services to support genomics, bioinformatics, clinical diagnostics, and data analytics. Its product suite includes the Seven Bridges bioinformatics environment, the Clinical Genomics Workspace for NGS interpretation and reporting, the ARIA data harmonization platform, and an IVD-grade Knowledgebase for variant interpretation.

Velsera's platform processes over 250,000 NGS samples annually and supports more than 80 active clinical NGS laboratory customers. The company's technical work spans AI, bioinformatics, genomics, and data harmonization.